UW Pathology Grand Rounds - Dr. Michael Haffner - Histomorphological Clues in Prostate Cancer
Michael Haffner, MD, PhD Assistant Professor, UW Dept. of Pathology, GU Division Assistant Professor, Fred Hutch, Clinical Research & Human Biology Divisions “Histomorphological Clues in Prostate Cancer: Lessons Learned from Molecular Pathology Studies” Prostate cancer is the most common malignancy in men in the US. Although diagnosis and treatment of prostate cancer have greatly improved over the past decade, there is still a lot to be learned about this complex disease. Histomorphological assessment of prostate cancer can provide a unique opportunity to uncover important biological clues. In this seminar, we will review novel insight into prostate cancer biology through the lens of the pathologist and we will explore molecular alterations that contribute to morphological changes that are used diagnostically. After viewing this lecture, attendees should be able to: 1) Understand relevant genomic alterations in prostate cancer. 2) Understand the clonal heterogeneity of prostate cancer. 3) Appreciate the interplay between molecular changes and histomorphologies.

UW Pathology Resident Slide Seminar - Dr. Lynette Sholl (Harvard) - The Spectrum of Lung Neoplasia

Contemporary Gleason Grading of Prostate Cancer - Complete Guide

Optimal Duration of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Dialectical Behavior Therapy (DBT): Where We Were, Where We Are and Where Are We Going

UROWebinar: WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant?

TypeScript in Express – TypeScript Tutorial

Stop Blind Biopsies: Near-Perfect Prostate Cancer Accuracy with Dr. Mark Emberton - EP 170

A Dummies Guide to Bladder Cancer Diagnosis

Laura Collins MD - Virtual Pathology Grand Rounds - June 24, 2020

Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows

USCAP: Jason Hornick's Deep Soft Tissue Tumors, Spindle Cell Tumors

Prostate Cancer Bone Metastases: The Hard Truth About Current Treatments

Bone Metastases & Spot Radiation #ProstateCancer | #MarkScholzMD #AlexScholz

Gleason 3+4 vs 4+3: Which One Is More Dangerous?

Prostate Cancer: Biochemical Recurrence

A Dummies Guide to Prostate Cancer Diagnosis

Metastatic Prostate Cancer: What It Really Means (Not What You Think)

Bladder and Testes Slide Session with Dr. Jennifer Gordetsky

Stereotactic Body Radiation Therapy (SBRT) Prostate Cancer spread to bones, nodes & tissues–162

